Aurinia Pharmaceuticals Inc (AUPH)

[Churchill54]

It’s been awhile. I’m sure like other Ariad veterans here, we have learned how to be patient. I think the next three months will determine if our patience will be justified. I am anticipating favorable DES results and a Voc approval within that time. I also expect the patent issue to be resolved with an extension through 2037. These three catalysts should facilitate a share price in the high 20’s. More importantly these catalysts should result in the company being acquired with a premium resulting in a 35-40 sp in 2021. I am very confident these events will occur. Despite the prolonged inactivity things are about to happen which will result in a very lucrative payday for all of us with the exception of the two shorts on this board.